Treace Medical Concepts(TMCI.US) Director Buys US$151.33K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director TREACE JAMES T purchased 25,000 shares of common stock on May 31, 2024 at an average price of $6.0531 for a total value of $151.33K.Source: Announcement Wha
Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Treace Medical Concepts (TMCI) and Veeva Systems (VEEV)
Treace Medical Concepts(TMCI.US) Director Buys US$130.06K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director TREACE JAMES T purchased 25,000 shares of common stock on May 29, 2024 at an average price of $5.2025 for a total value of $130.06K.Source: Announcement Wha
Treace Medical Concepts(TMCI.US) Director Buys US$253.47K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director TREACE JAMES T purchased 50,000 shares of common stock on May 28, 2024 at an average price of $5.0695 for a total value of $253.47K.Source: Announcement Wha
Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing
James T Treace, Director, on May 28, 2024, executed a purchase for 50,000 shares in Treace Medical Concepts (TMCI) for $253,475. Following the Form 4 filing with the SEC, Treace has control over a tot
Treace Medical Concepts(TMCI.US) Director Buys US$93,501 in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director MOTT RICHARD W purchased 18,000 shares of common stock on May 24, 2024 at an average price of $5.1945 for a total value of $93,501.Source: Announcement What
Treace to Present at Truist Securities MedTech Conference
PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions
Treace Medical Concepts(TMCI.US) Director Buys US$60,424.98 in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director MOTT RICHARD W purchased 12,100 shares of common stock on May 22, 2024 at an average price of $4.9938 for a total value of $60,424.98.Source: Announcement W
Express News | Treace Medical Outlook FY Revenue USD 201-211 Million
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Treace Medical Concepts(TMCI.US) 10% Shareholder Buys US$556.17K in Common Stock
$Treace Medical Concepts(TMCI.US)$ 10% Shareholder Treace John T. purchased 100K shares of common stock on May 17, 2024 at an average price of $5.5617 for a total value of $556.17K.Source: Announcemen
Unveiling 6 Analyst Insights On Treace Medical Concepts
Analysts' ratings for Treace Medical Concepts (NASDAQ:TMCI) over the last quarter vary from bullish to bearish, as provided by 6 analysts.The following table summarizes their recent ratings, shedding
UBS Downgrades Treace Medical, Cites Increasing Competition
Treace Medical Concepts Cut to Neutral From Buy by UBS
Treace Medical Concepts Cut to Neutral From Buy by UBS
UBS: Downgraded the Treace Medical Concepts (TMCI.US) rating from buy to neutral, and adjust the target price from $16.00 to $6.50.
UBS: Downgraded the Treace Medical Concepts (TMCI.US) rating from buy to neutral, and adjust the target price from $16.00 to $6.50.
Treace Medical Concepts Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 12.75% UBS $16 → $6.5 Downgrades Buy → Neutral 05/08/2024 -4.6% Morgan Stanley $15 → $5.5 Downg
UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16
Treace Medical Concepts (TMCI) has an average rating of Hold and price targets ranging from $5.50 to $8, according to analysts polled by Capital IQ. Price: 5.73, Change: -0.22, Percent Change: -3.71
OPEN, BCRX and AWIN Among Pre-market Gainers
Director Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)
Treace Medical Concepts(TMCI.US) Director Buys US$100K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director Kiernan Jane E purchased 19,356 shares of common stock on May 14, 2024 at an average price of $5.1664 for a total value of $100K.Source: Announcement What i
No Data